Abstract:Abstract Type III CRISPR-Cas systems provide a sequence-specific adaptive immune response that protects prokaryotic hosts against viruses and other foreign genetic invaders. These crRNA-guided Cas effector complexes bind and cleave complementary RNA targets. Specific target binding stimulates the Cas10 subunit to generate cyclic oligoadenylate (cOA) signaling molecules, that in turn allosterically activate proteins carrying cognate sensory domains: CARF or SAVED. Here, we characterize an elaborate set of genes associated with the type III-B CRISPR-Cas system from Haliangium ochraceum , which includes a signal transduction module of a CBASS defense system with two caspase-like proteases, SAVED-CHAT and PCaspase (Prokaryotic Caspase). We show that binding of a 3-nucleotide cOA (cA 3 ) to the SAVED domain of SAVED-CHAT induces its oligomerization into long filaments that activate the proteolytic activity of the CHAT domain. Surprisingly, we find that activated SAVED-CHAT specifically cleaves and activates the second protease, PCaspase. In turn, activated PCaspase cleaves a multitude of other proteins, including a putative sigma factor and a PCaspase-inhibitor. We expressed the type III-B system and its associated genes in E. coli and observed a strong abortive phenotype when offering a complementary target RNA, but only in the presence of both SAVED-CHAT and PCaspase. Together, our findings show an intriguing cascade of proteolytic activities (conceptually similar to eukaryotic caspases) in this bacterial immune system that reveals yet another strategy to effectively defend against mobile genetic elements.

Csx28 is a membrane pore that enhances CRISPR-Cas13b–dependent antiphage defense

CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23

Csx3 is a cyclic oligonucleotide phosphodiesterase associated with type III CRISPR–Cas that degrades the second messenger cA4

The CRISPR effector Cam1 mediates membrane depolarization for phage defence

Structural basis for regulation of a CBASS-CRISPR-Cas defense island by a transmembrane anti-σ factor and its ECF σ partner

Cas1 mediates the interference stage in a phage-encoded CRISPR–Cas system

Target RNA-guided protease activity in type III-E CRISPR–Cas system

Antiviral type III CRISPR signalling via conjugation of ATP and SAM

Target RNA activates the protease activity of Craspase to confer antiviral defense

Cas1 mediates the interference stage in a phage-encoded CRISPR-Cas system

Mechanistic insights into DNA binding and cleavage by a compact type I-F CRISPR-Cas system in bacteriophage

Type III-B CRISPR-Cas signaling-based cascade of proteolytic cleavages

Structural insight into the Csx1-Crn2 fusion self-limiting ribonuclease of type III CRISPR system

Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6

Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex

Pro-CRISPR PcrIIC1-associated Cas9 system for enhanced bacterial immunity

Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity

Structure and function of a bacterial type III-E CRISPR–Cas7-11 complex

Molecular Mechanisms Of Iii-B Crispr-Cas Systems In Archaea

Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers

Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR–Cas Systems